North Rock Partners, LLC Atossa Therapeutics, Inc. Transaction History
North Rock Partners, LLC
- $3.04 Billion
- Q4 2024
A detailed history of North Rock Partners, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, North Rock Partners, LLC holds 16,750 shares of ATOS stock, worth $12,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,750
Previous 16,750
-0.0%
Holding current value
$12,227
Previous $25,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATOS
# of Institutions
90Shares Held
29MCall Options Held
39.8KPut Options Held
90.9K-
Black Rock Inc. New York, NY9.2MShares$6.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$4.83 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.81MShares$2.05 Million0.0% of portfolio
-
State Street Corp Boston, MA1.76MShares$1.28 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.56MShares$1.14 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $92.4M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...